Takeyama, Masahiro
Nogami, Keiji
Kobayashi, Ryohei
Ogiwara, Kenichi
Taniguchi, Akira
Nakanishi, Yasuaki
Inagaki, Yusuke
Tanaka, Yasuhito
Shima, Midori
Funding for this research was provided by:
Novo Nordisk
Bayer
Shire
Bioverative
Chugai Pharmaceutical
Pfizer
KAKETSUKEN
Article History
Received: 13 October 2017
Revised: 23 January 2018
Accepted: 24 January 2018
First Online: 30 January 2018
Compliance with ethical standards
:
: Takeyama M, Ogiwara K, Inagaki Y, and Tanaka Y have received funding for their research from Novo Nordisk. Nogami K has received funding for his research from Novo Nordisk, Bayer, Shire, Bioverative, Chugai, and KAKETSUKEN. Shima M has received funding for his research from Novo Nordisk, Bayer, Shire, Pfizer, Bioverative, Chugai, and KAKETSUKEN. Kobayashi R, Taniguchi A, and Nakanishi Y have no conflicts of interest.